comparemela.com

Latest Breaking News On - Athira pharma - Page 1 : comparemela.com

Forefront Analytics LLC Grows Stake in Athira Pharma, Inc. (NASDAQ:ATHA)

Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]

Athira-pharma
Nan-fung-group-holdings-ltd
Athira-pharma-inc
Forefront-analytics
Exchange-commission
Advisor-group
Clarius-group
Laird-norton-trust-company
Nasdaq
Barclays-plc
Free-report
Norton-trust-company

Athira Pharma, Inc. (NASDAQ:ATHA) Sees Large Drop in Short Interest

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]

Athira-pharma
Laird-norton-trust-company
Athira-pharma-inc
Forefront-analytics
Advisor-group
Clarius-group
Nasdaq
Athira-pharma-company-profile
Get-free-report
Capital-partners
Norton-trust-company
Pharma-stock-down

Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Down 12.1% in May

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]

Athira-pharma
Laird-norton-trust-company
Clarius-group
Advisor-group
Forefront-analytics
Athira-pharma-inc
Athira-pharma-company-profile
Nasdaq
Get-free-report
Capital-partners
Norton-trust-company
Pharma-stock-down

Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Down 12.1% in May

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a decrease of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily volume of 309,500 shares, […]

Athira-pharma
Nan-fung-group-holdings-ltd
Acadian-asset-management
Barclays-plc
Nasdaq
Athira-pharma-inc
Jacobs-levy-equity-management-inc
Perceptive-advisors
Athira-pharma-company-profile
Get-free-report
Asset-management
Levy-equity-management

Athira Pharma To Participate In Upcoming June Conferences

Management to Highlight Robust Pipeline in Neurodegenerative Diseases with Key Phase 2/3 LIFT-AD Topline Data in Alzheimer s Disease on Track for Sec

Miami-beach
Florida
United-states
Washington
New-york
Miami
Seattle
Athira-pharma
Julie-rathbun
Instagram
Twitter
Nasdaq

vimarsana © 2020. All Rights Reserved.